CAPRICOR THERAPEUTICS, INC. Contract with Customer, Liability, Noncurrent
CAPRICOR THERAPEUTICS, INC. (CAPR) had Contract with Customer, Liability, Noncurrent of $0 as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2024-03-11
- 2023-12-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2023-09-30: Contract with Customer, Liability, Noncurrent $953.47K.
- 2023-06-30: Contract with Customer, Liability, Noncurrent $3.23M.
- 2023-03-31: Contract with Customer, Liability, Noncurrent $5.45M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-11 |
| 2023-09-30 | $953.47K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.23M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.45M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $9.47M 10-K · filed 2024-03-11 |
| 2022-09-30 | $9.85M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $14.25M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $20.27M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |